Nationwide, an estimated 1.2 million people are eligible to receive medication that can prevent the spread of life-threatening HIV infection. But only roughly a third of those eligible are currently ...

The investigational oral pre-exposure prophylaxis (PrEP) agent MK-8527 showed a similar, well-tolerated safety profile to placebo, with dose-proportional pharmacokinetics, among adults with a low ...

The Red & Black is a 501c3 nonprofit. Please consider a one-time gift or become a monthly supporter. Cancel anytime. The Northeast Health District is expanding resource availability of PrEP, a ...

Meeting UNAIDS’ “95/95/95” targets for 2025—95% of people with HIV knowing their status, 95% of those who know their status on treatment, and 95% of people on treatment having a suppressed viral ...

Cost and insurance coverage issues significantly hinder PrEP uptake, especially among those with delayed or non-pickup of prescriptions. Transgender individuals face lower PrEP adoption rates compared ...